Company Filing History:
1 out of 81 
1 out of 5 Years Active: 2014
Title: Sean Deacon: Innovator in Cancer Research
Introduction
Sean Deacon is a notable inventor based in Philadelphia, PA. He has made significant contributions to the field of cancer research through his innovative work. His expertise and dedication have led to the development of important patents that aim to advance medical science.
Latest Patents
Sean Deacon holds a patent titled "Inhibition of activated cdc42-associated kinase 1." This patent focuses on compounds, compositions, and methods for the specific inhibition of activated cdc42-associated kinase 1 (Ack1). His work in this area is crucial for developing targeted therapies in cancer treatment.
Career Highlights
Throughout his career, Sean has worked with esteemed organizations such as Fox Chase Cancer Center and Reaction Biology Corporation. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Sean's notable coworkers include Jeffrey R. Peterson and Haiching Ma. Their collaborative efforts have further enhanced the impact of his research and innovations.
Conclusion
Sean Deacon's contributions to cancer research through his patent and collaborations highlight his commitment to advancing medical science. His work continues to inspire future innovations in the field.